Muscular Dystrophy Research Today is a free monthly online journal that collates and summarizes the latest research about Muscular Dystrophy, including details on duchenne muscular dystrophy, symptoms, treatment.

Volume 1 (2005), Issue 2 (February)

1. Ullrich congenital muscular dystrophy: connective tissue abnormalities in the skin support overlap with Ehlers-Danlos syndromes.
   Am J Med Genet A, 132(3): 296-301. [Abstract] [Full-text]
2. Cardiac involvement in Emery-Dreifuss muscular dystrophy.
   Clin Genet, 67(3): 220-3. [Abstract] [Full-text]
3. A new model mouse for Duchenne muscular dystrophy produced by 2.4 Mb deletion of dystrophin gene using Cre-loxP recombination system.
   Biochem Biophys Res Commun, 328(2): 507-16. [Abstract] [Full-text]
4. (GCG)11 founder mutation in the PABPN1 gene of OPMD Uruguayan families.
   Neuromuscul Disord, 15(2): 185-90. [Abstract] [Full-text]
5. Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures.
   Neuromuscul Disord, 15(2): 164-71. [Abstract] [Full-text]
6. The function of Myostatin and strategies of Myostatin blockade-new hope for therapies aimed at promoting growth of skeletal muscle.
   Neuromuscul Disord, 15(2): 117-26. [Abstract] [Full-text]
7. In vivo expression of myosin essential light chain using plasmid expression vectors in regenerating frog skeletal muscle.
   Gene Ther, 12(4): 347-57. [Abstract] [Full-text]
8. Atrial fibrillation following chemotherapy for stage IIIE diffuse large B-cell gastric lymphoma in a patient with myotonic dystrophy (Steinert's disease).
   Ann Hematol, 84(3): 192-3. [Abstract] [Full-text]
9. Alendronate in the treatment of low bone mass in steroid-treated boys with Duchennes muscular dystrophy.
   Arch Phys Med Rehabil, 86(2): 284-8. [Abstract] [Full-text]
10. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
    J Biol Chem, 280(7): 5773-80. [Abstract] [Full-text]
11. Oculopharyngeal muscular dystrophy (OPMD): analysis of the PABPN1 gene expansion sequence in 86 patients reveals 13 different expansion types and further evidence for unequal recombination as the mutational mechanism.
    Hum Genet, 116(4): 267-71. [Abstract] [Full-text]
12. Genetic confirmation of facioscapulohumeral muscular dystrophy in a case with complex D4Z4 rearrangments.
    Hum Genet, 116(4): 262-6. [Abstract] [Full-text]
13. Localization and functional analysis of the LARGE family of glycosyltransferases: significance for muscular dystrophy.
    Hum Mol Genet, 14(5): 657-65. [Abstract] [Full-text]
14. Low-dose metformin improves hyperglycaemia related to myotonic dystrophy.
    Diabet Med, 22(3): 346-7. [Abstract] [Full-text]
15. Oculopharyngeal muscular dystrophy with PABPN1 mutation in a Chinese Malaysian woman.
    Neuromuscul Disord, 15(3): 262-4. [Abstract] [Full-text]
16. Localized expression of specific P2X receptors in dystrophin-deficient DMD and mdx muscle.
    Neuromuscul Disord, 15(3): 225-36. [Abstract] [Full-text]
17. The frequency of limb girdle muscular dystrophy 2A in northeastern Italy.
    Neuromuscul Disord, 15(3): 218-24. [Abstract] [Full-text]
18. Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J.
    Neurology, 64(4): 636-42. [Abstract] [Full-text]
19. Hyperkalemic cardiac arrest after cardiopulmonary bypass in a child with unsuspected duchenne muscular dystrophy.
    Anesth Analg, 100(3): 672-4, table of contents. [Abstract] [Full-text]
20. Mutations in POMT1 are found in a minority of patients with Walker-Warburg syndrome.
    Am J Med Genet A, 133(1): 53-7. [Abstract] [Full-text]
21. Enrichment of the R77C alpha-sarcoglycan gene mutation in Finnish LGMD2D patients.
    Muscle Nerve, 31(2): 199-204. [Abstract] [Full-text]

© 2005-2008 Muscular Dystrophy Research Today. All Rights Reserved.